Endovascular salvage of thrombosed haemodialysis vascular access

Deogaonkar, Ganesh; Thulasidasan, Narayanan; Phulambrikar, Rutuja; Διαμαντόπουλος, Αθανάσιος; Sran, Kiran; Ahmed, Irfan; Loukopoulos, Ioannis; Karunanithy, Narayan

doi:10.1024/0301-1526/a001043

Cited by 7 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Rheolytic and continuous aspiration thrombectomy techniques are often dependent on adjunctive thrombolytics [7] and can result in uncomfortable side-effects such as chest pain [11] . Furthermore, these treatments do not have a mechanism to remove wall-adherent or organized thrombus, a significant limitation as complete thrombus removal is essential to improve treatment durability [12] . As demonstrated here, InThrill was able to rapidly remove all acute to chronic thrombus without thrombolytics.…”

Section: Discussionmentioning

confidence: 99%

Treating hemodialysis access thrombosis with the InThrill Thrombectomy System: Technique and case report

Wright,

Schneider

2024

Radiology Case Reports

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Treating hemodialysis access thrombosis with the InThrill Thrombectomy System: Technique and case report

Wright,

Schneider

2024

Radiology Case Reports

View full text Add to dashboard Cite

The Delay of Recanalisation of Acutely Thrombosed Dialysis Arteriovenous Access Until the Next Workday has No Negative Impact on Clinical Outcome

Hellwig,

Zicha,

Kopp

et al. 2024

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

Purpose The necessity of providing endovascular recanalization of acutely thrombosed arteriovenous access (AV access) during weekend is questionable, since hemodialysis can alternatively be achieved by temporarily placed non-tunneled central venous catheters (CVC). Interventional therapy of acutely thrombosed AV access is provided only on weekdays in the study center. This study aimed to compare outcomes in patients admitted on weekdays and on the weekend. Methods A total of 355 endovascular procedures for thrombosed AV access performed in a single tertiary center from 2007 to 2017 were retrospectively analyzed for technical and clinical success, complications, rate of CVC and length of hospitalization. Technical success was defined as adequate blood flow with less than 30% residual stenosis, clinical success was defined as at least one successful hemodialysis after recanalization. There were two groups: patients who had to wait at least 2 days for recanalization due to admission at the weekend (n = 59, at-the-weekend group, ATW group) and patients receiving therapy no later than the day after admission (n = 296, on a working day group, OAW group). Results The technical/clinical success rate was 96.6%/88.1% in the ATW and 89.1%/84.6% in the OAW group (p > .05). Complications did not differ among groups (p > .05). Despite a higher rate of CVC, no attributed additional adverse events or complications were observed in the ATW group (p > .05). Conclusion Despite a longer time until treatment and a higher rate of short-term CVC, it seems to be justified to provide recanalization of dialysis shunts only during weekdays. Graphical Abstract

show abstract

Combined treatment of dysfunctional dialysis access with cutting balloon and paclitaxel-coated balloon in real world

Böhme

Noory

Beschorner

et al. 2023

Vasa

View full text Add to dashboard Cite

Summary: Background: Dysfunction in arteriovenous (AV) access is a common reason for subsequent intervention. To evaluate the results of endovascular treatment of AV access lesions using cutting balloon (CB) and drug-coated balloon (DCB) angioplasty compared to standard treatment using plain-old balloon angioplasty (POBA). Patients and methods: Patients who retrospectively were selected from a prospectively maintained database. Primary endpoint was primary patency rate at the target lesion up to 12 months after index procedure. Secondary endpoints were the acute treatment success, the “bail out” stent rate, primary patency at 6 months, freedom from target lesion revascularization (TLR), AV access replacement and surgical revision during a follow-up period up to 12 months, and all-cause mortality rate stratified to patients treated with and without DCB. Results: One hundred and eighty-four patients met the inclusion criteria. POBA as stand alone or combined with DCB angioplasty was performed in 71 patients (38.6%), CB in 54 patients (29.3%), and in 59 patients (32.1%), both CB and DCB were used. Primary patency rate at 12 months was 31.6% for the POBA/DCB-group, 52.3% for the CB-group, and 64.8% for the CB/DCB-group, respectively. In total, 80 patients (51.6%) had a TLR including endovascular or surgical revision, or a shunt replacement. All-cause mortality at 12 months was 7.2% in the DCB group and 9.1% in the group of patients treated without a DCB (p=0.747). Conclusions: The use of CB seems to be crucial for a better outcome. The combination of CB and DCB achieves the best patency results at mid-term.

show abstract

Endovascular salvage of thrombosed haemodialysis vascular access

Cited by 7 publications

References 21 publications

Treating hemodialysis access thrombosis with the InThrill Thrombectomy System: Technique and case report

Treating hemodialysis access thrombosis with the InThrill Thrombectomy System: Technique and case report

The Delay of Recanalisation of Acutely Thrombosed Dialysis Arteriovenous Access Until the Next Workday has No Negative Impact on Clinical Outcome

Combined treatment of dysfunctional dialysis access with cutting balloon and paclitaxel-coated balloon in real world

Contact Info

Product

Resources

About